Momenta Pharmaceuticals Inc - 02142 Cambridge, MA

Business Name: Momenta Pharmaceuticals Inc
Categorized In:
Address: 675 West Kendall St, Cambridge, MA 02142
Phone Number: (617) 491-9700
Contact Person: Craig Wheeler, Chief Executive Officer
Website Address: momentapharma.com
NAICS Code: 3254140
SIC Code: 2834
Business Type: B2B & B2C
Founding Year: 2001
Employee #: 1 to 4
Location Type: Headquarters
Annual Revenue ($): Unknown
Share This Business:
Similar Businesses: Il Pharma Inc - Cambridge, MA 02142
Newco Ls13 - Cambridge, MA 02142
Sanofi Us Services Inc - Cambridge, MA 02142
Shape Pharmaceuticals Inc - Cambridge, MA 02142
Verastem Inc - Cambridge, MA 02142
Targanta Therapeutics Corporation - Cambridge, MA 02142
Edimer Pharmaceuticals - Cambridge, MA 02142
Eleven Biotherapeutics - Cambridge, MA 02142
Constellation Pharmaceuticals - Cambridge, MA 02142
Millennium Pharmaceuticals - Cambridge, MA 02142
Aegerion Pharmaceuticals Inc - Cambridge, MA 02142
Via Cord LLC - Cambridge, MA 02142
Lipomed Inc - Cambridge, MA 02142
Ironwood Pharmaceuticals Inc - Cambridge, MA 02142
Alnylam Pharmaceuticals Inc - Cambridge, MA 02142
Sarepta Therapeutics Inc - Cambridge, MA 02142
Zalicus Inc - Cambridge, MA 02142
Clarus Ventures LLC - Cambridge, MA 02142
Gloucester Pharmaceuticals Inc - Cambridge, MA 02142
Akanas Therapeutics Inc - Cambridge, MA 02142

Momenta Pharmaceuticals Inc provides professional from its headquarters at the coordinates 42.36446,-71.08192.

The company offers BOTH variables under the SIC code 2834 and NAICS code 3254140, while making an annual revenue of Unknown and hiring a total of 1 to 4 employees.

Founded in 2001, the company can now be visited at 675 West Kendall St, Cambridge, Massachusetts 02142 or contacted through representative Craig Wheeler, Chief Executive Officer at (617) 491-9700.

For frequently asked questions and further inquiries about professional , get to know more about Momenta Pharmaceuticals Inc through its company website at momentapharma.com. Engage with this business on its social media platforms through on Twitter and on Facebook.